Skip to content

Screening for Silent Atrial Fibrillation During Influenza Vaccination

Screening for Silent Atrial Fibrillation During Influenza Vaccination

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02006524
Enrollment
3269
Registered
2013-12-10
Start date
2013-10-31
Completion date
2014-12-31
Last updated
2016-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Keywords

Silent atrial fibrillation, primary care, screening, influenza vaccination

Brief summary

Silent atrial fibrillation is an important cause of unnecessary strokes. If diagnosed and treated in time with anticoagulants, many disabling strokes can be prevented. In order to improve the diagnosis of atrial fibrillation the MyDiagnostick is developed; a user friendly and easy to use stick that diagnoses atrial fibrillation in one minute. During influenza vaccination, many patients who are also at risk for atrial fibrillation visit the general practice. This offers an ideal opportunity for screening for atrial fibrillation. The study investigates the yield of screening for atrial fibrillation with the MyDiagnostick during influenza vaccination (newly detected atrial fibrillation with corresponding CHA2DS2-Vasc score).

Interventions

DEVICE'MyDiagnostick

Sponsors

Boehringer Ingelheim
CollaboratorINDUSTRY
UMC Utrecht
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Eligible for influenza vaccination

Exclusion criteria

* Not eligible for influenza vaccination

Design outcomes

Primary

MeasureTime frame
Newly detected AFduring influenza vaccination

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026